Giant alcohol retailer inked a $104M deal with a major cannabis company to build and operate a string of cannabis dispensaries.
The stock for this alcohol mega-player could see a big move as it makes a strategic shift into cannabis.
I'll uncover this stock and break down this deal in my complimentary report.
I will also send you a free, weekly newsletter where I'll share trends, highlight different cannabis stocks, share the performance of my model portfolio, and more.
About Michael Vodicka
Michael Vodicka is an equity analyst with more than 20 years of experience in trading and investing. His research has been featured in some of the industry's most respected publications.
He has been investing and leading investors in the cannabis sector since 2013. Now, Mr. Vodicka brings his expertise and guidance to the members of CST.